SHVM congress

SHVM congress

Our COST action is pleased to sponsor the 22nd Annual Meeting of the Society for Heart and Vascular Metabolism (SHVM), to be held in Bordeaux, France, from Sunday, June 22nd to Wednesday, June 25th, 2025.

The scientific focus of the 2025 meeting is “Shedding Light on Emerging Metabolic Targets in Cardiovascular Diseases”.

Abstract deadline extension: March 28th with several slots for posters and oral presentations.

Website: https://shvm2025.azuleon.org/welcome

Share this post

Twitter
Facebook
LinkedIn
WhatsApp

Latest Updates

Postdoctoral Position in Paris

WG4 METAHEART CA Webinar

From Omics to Mechanisms: Mechano-Energetic Uncoupling in Heart Failure

Newsletter

Subscribe our Newsletter and stay up-to-date

Stay Up-to-date

Guido Kroemer’s team in Paris is seeking to recruit outstanding postdoctoral fellows with strong expertise in molecular and cellular biology, immunology, and/or physiology to investigate the role of ACBP/DBI, a...
May 19th, 13.00 London Time, 14.00 Berlin Time Hosts: Prof Dunja Aksentijevic (UK) WG4 lead, Prof Simon Sedej (Austria) & Dr Edoardo Bertero (Italy) WG4 Deputy Leads
Wednesday 22nd April, 12.00 GMTJoin us on Zoom – click here to register. Hosts: Prof Dunja Aksentijevic (UK) WG4 lead, Prof Simon Sedej (Austria) &Dr Edoardo Bertero (Italy) WG4 Deputy...
📆 Deadline: Submission for applications is open until May 1, 2026. 🤝 Work together, exchange technology & build new scientific collaborations within EU-METAHEART COST Action. ➡️ STSMs are THE way to...
Save-the-Date AMPK 2026
📍 Lunteren, Netherlands📅 27–29 September 2026This 3-day meeting will bring together leading experts and early-career researchers to discuss the latest advances in AMPK signaling, nutrient sensing pathways, and their roles...
👏 Congratulations to our EU-METAHEART COST Action WG4 leader Dunja Aksentijevic Ricciarelli for the publication of her new study in Nature Cardiovascular Research: https://lnkd.in/db3WWu_Q💡 “Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2...